- Related Symbols
- TGRT
These 3 Active Growth ETFs’ Charts Are Sending Buy Signals
Heard a lot about active investing and ETFs, but not sure where to begin? Three active growth ETFs are sending out key buy signals amid spiking returns. Those funds could offer a place to start, whether via tax-loss harvesting proceeds or as part of a broader portfolio reshuffle. With active on the rise and a soft landing potentially on the horizon, active growth could offer some potent value.See more: It’s Tax-Loss Harvesting Season. Here’s How Active ETFs Can Help
Why look to active growth ETFs in the first place? Active investing offers investors more flexibility than passive funds can. Should market-leading mega-cap names shift, active adaptability could prove a potent tool. What’s more, many active strategies lean on fundamental research to take a bottom-up approach to stock selection.
That said, the following three active growth ETFs are sending buy signals per their tech charts. Technical charts send buy signals when the price of a given security rises above either its 50- or 200-day Simple Moving Average (SMA).Active Growth ETFs to WatchThe T. Rowe Price Blue Chip Growth ETF (TCHP C+), for example, has stood out over the last month. TCHP returned almost 9% at that time, per ETF Database data. Over the last year, the fund has returned 46% per T. Rowe Price data, beating its benchmark’s 36% return.
Charging just a 57 basis point (bps) fee, the fund recently hit its fifth anniversary. It looks for established firms with seasoned management, dividend growth, and strong financial fundamentals. The ETF’s price of $40.08 as of Oct. 9 sat well above both its 50 and 200-day SMAs per YCharts. Those averages sat at $38.29 and $35.99, respectively.
Elsewhere, the T. Rowe Price Growth Stock ETF (TGRW C) is also sending a buy signal. Charging a smaller 52 bps fee, it actively invests in firms with growth characteristics like earnings momentum stability. The fund also seeks out companies with the capacity to expand during unfavorable economic conditions. It has returned 7.5% over the last month, also beating its averages. The fund’s $37.83 price sat above both its SMAs as of Oct. 9, according to YCharts data, at $36.49 (50) and $34.77 (200). The strategy has returned 39.4% over one year, beating its benchmark.
Finally, the T. Rowe Price Growth ETF (TGRT B+) presents one more strategy among active growth ETFs, sending a buy signal. TGRT charges only 38 bps for its active approach, applying fundamental, bottom-up active stock selection to large caps. The fund has returned 8% over the last month per ETF Database. According to T. Rowe Price data, it has returned 44.1% over the last year, beating its benchmark. The fund’s price of $36.17 as of Oct. 9 on YCharts sat above its $34.77 50-day SMA and its $32.78 200-day SMA.
Together, the three active growth ETFs offer investors different price and entry points for a potential soft landing. With potent momentum, they could offer an option to add some active growth oomph to portfolios.
For more news, information, and analysis, visit our Active ETF Channel.
More Commentary
Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.
ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.
For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.
FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.
News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.
Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.
Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.